SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Profectus BioSciences, Inc. Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine